New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Tirzepatide works by suppressing two appetite ... It was previously only available in single doses. Mounjaro is expected to provide an alternative to Wegovy — or semaglutide — which has ...

Tirzepatide injection, branded as Mounjaro and Zepbound, has been in shortage since 2022 due to increased demand. The U.S. health regulator reminded compounders of the legal restrictions on making ...

The National Institute for Health and Care Excellence is consulting on a phased roll-out of Eli Lilly’s weight loss drug tirzepatide – more commonly known as Mounjaro – as NHS England looks to combat ...

Dubbed the “King Kong” of weight loss jabs, Mounjaro, the brand name for tirzepatide, is a weekly injection licensed to treat type 2 diabetes on the NHS. Trials have shown some users can lose ...